Category: Press Release - Psilocybin Alpha

New Resource: Psychedelics Drug Development Tracker

Optimi Health Completes Pre-Clinical Trial Application Meeting

Optimi Health Completes Pre-Clinical Trial Application Meeting

Post published:June 15, 2021
Post category:Press Release

PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression

PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression

Post published:June 15, 2021
Post category:Press Release

Field Trip Health Ltd. Announces Completion of DMPK Studies, Engineering Batch for FT-104, Its Novel Psychedelic Compound

Field Trip Health Ltd. Announces Completion of DMPK Studies, Engineering Batch for FT-104, Its Novel Psychedelic Compound

Post published:June 15, 2021
Post category:Press Release

Filament Announces First GMP Batch of Pharmaceutical Grade Natural Psilocybin

Filament Announces First GMP Batch of Pharmaceutical Grade Natural Psilocybin

Post published:June 11, 2021
Post category:Press Release

atai Life Sciences Announces Launch of Initial Public Offering

atai Life Sciences Announces Launch of Initial Public Offering

Post published:June 11, 2021
Post category:Press Release

Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit Now Available for Sale in US

Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit Now Available for Sale in US

Post published:June 10, 2021
Post category:Press Release

Red Light Holland Closes Acquisition of 80% of Happy Caps Mushroom Farm – Specializing in Grow-At-Home Mushroom Kits

Red Light Holland Closes Acquisition of 80% of Happy Caps Mushroom Farm – Specializing in Grow-At-Home Mushroom Kits

Post published:June 10, 2021
Post category:Press Release

PharmaTher Provides Research and Development Update and Milestones for 2021

PharmaTher Provides Research and Development Update and Milestones for 2021

Post published:June 10, 2021
Post category:Press Release

MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder Drugs

MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder Drugs

Post published:June 10, 2021
Post category:Press Release

MindMed Announces Chief Executive Officer Transition

MindMed Announces Chief Executive Officer Transition

Post published:June 9, 2021
Post category:Press Release

End of content

No more pages to load

Psilocybin Alpha

The definitive resource for investors in the emergent psychedelic medicine sector. Cut through the shroom stock noise with exclusive news, interviews, data and private financing opportunities.

Quick Links

Newsletter

Industry insights and interviews delivered to your inbox. No spam, just valuable information.